4//SEC Filing
Backus William A. 4
Accession 0001140361-24-009784
CIK 0000009326other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:58 PM ET
Size
19.0 KB
Accession
0001140361-24-009784
Insider Transaction Report
Form 4
BALCHEM CORPBCPC
Backus William A.
CAO and Assistant Treasurer
Transactions
- Exercise/Conversion
Common Stock
2024-02-23$84.40/sh+5,480$462,512→ 18,394 total - Exercise/Conversion
Common Stock
2024-02-23$74.57/sh+3,700$275,909→ 22,094 total - Sale
Common Stock
2024-02-23$156.94/sh−2,477$388,745→ 12,914 total - Exercise/Conversion
Stock Options (right to buy)
2024-02-23−5,480→ 0 totalExercise: $85.40Exp: 2027-02-21→ Common Stock (5,480 underlying) - Exercise/Conversion
Stock Options (right to buy)
2024-02-23−3,700→ 0 totalExercise: $74.57Exp: 2028-02-15→ Common Stock (3,700 underlying) - Sale
Common Stock
2024-02-23$156.16/sh−6,703$1,046,724→ 15,391 total - Sale
Common Stock
2024-02-26$154.36/sh−2,581$398,408→ 10,333 total - Sale
Common Stock
2024-02-26$155.66/sh−4,319$672,284→ 6,014 total - Sale
Common Stock
2024-02-26$156.13/sh−100$15,613→ 5,914 total
Footnotes (7)
- [F1]Exercise of fully vested non-qualified stock options.
- [F2]This transaction was executed in multiple sales ranging from $155.4950 to $156.4825 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- [F3]This transaction was executed in multiple sales ranging from $156.5300 to $157.1950 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- [F4]This transaction was executed in multiple sales ranging from $154.0800 to $155.0300 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- [F5]This transaction was executed in multiple sales ranging from $155.1300 to $156.0500 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- [F6]Stock options that vested 20% on February 21, 2018, 40% on February 21, 2019, and 40% on February 21, 2020, and are exercisable.
- [F7]Stock options that vested 20% on February 15, 2019, 40% on February 15, 2020, and 40% on February 15, 2021, and are exercisable.
Documents
Issuer
BALCHEM CORP
CIK 0000009326
Entity typeother
Related Parties
1- filerCIK 0001530884
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:58 PM ET
- Size
- 19.0 KB